EUVIMEDEUVIMED entdecken
Open Access

PET Imaging of Tumor-Associated Macrophage Dynamics and Response to Clinical Treatment for Potential Translation

Gyu Seong Heo, Alexandria Li, Joan Tao, Jesse Meir Zaretsky, Deborah Sultan, Lisa Detering, Divangana Lahad, Hannah Luehmann, Xiaohui Zhang, Xiuli Zhang, Xuefeng Gao, Rajiu Venkatesan und 12 weitere

Journal of Nuclear Medicine · 2026-11 · 67 (11) · 1771-1776

DOI: 10.2967/jnumed.126.272473 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Journal of Nuclear Medicine, online erschienen am 03.09.2026. Verfasst von Gyu Seong Heo und 23 weiteren Autor:innen. Beteiligte Einrichtung: Mallinckrodt Institute of Radiology, School of Medicine, Washington University, St. Louis, Missouri. Hauptthemen laut MEDLINE: Positron-Emission Tomography, Tumor-Associated Macrophages, Head and Neck Neoplasms, Translational Research, Biomedical. Die Arbeit nennt 34 Literaturangaben. Der Volltext ist frei in PubMed Central verfügbar.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Tumor-associated macrophages (TAMs) are an important component of the tumor microenvironment (TME). The abundance and distribution of TAMs significantly affect the immune responses of TME to determine the tumor progression and treatment response of solid tumors such as head and neck squamous cell carcinoma (HNSCC). Molecular characterization of human HNSCC specimens and mouse models has identified CD163 as a unique biomarker for TAMs in HNSCC. The goal of this study was to determine the dynamic changes of CD163-positive TAMs in HNSCC progression and treatment response to assess the potential of a CD163 targeted radiotracer, 64Cu-ICT-01, in detecting CD163-positive TAMs for translation in HNSCC.

Methods

We assessed the capability of 64Cu-ICT-01 for noninvasive imaging of CD163-positive TAMs using PET. We determined its targeting specificity in multiple mouse HNSCC models to track the progression of tumors. We assessed its sensitivity in tracking variations of CD163-positive TAMs and correlation with tumor volumes after clinical treatment. We also measured its binding to CD163-positive TAMs upregulated on human HNSCC tissues.

Results

64Cu-ICT-01 PET specifically determined the spatiotemporal distribution of CD163-positive TAMs in a MOC1 cell line model and patient-derived xenograft HNSCC models. CD163 PET sensitively tracked the dynamics of CD163-positive TAMs after clinical treatment. Its tumor binding correlated with CD163 expression levels and the volumes of tumors. In human HNSCC specimens, 64Cu-ICT-01 showed strong and specific binding to human CD163.

Conclusion

64Cu-ICT-01 demonstrated accurate targeting of CD163 in both mouse tumor models and human HNSCC tissues. CD163 PET has great potential to be a noninvasive biomarker to measure TAM activities within TME, monitor treatment response, and optimize treatment strategy.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Positron-Emission TomographyTumor-Associated MacrophagesHead and Neck NeoplasmsTranslational Research, BiomedicalAnimalsHumansMiceCD163 AntigenAntigens, CDAntigens, Differentiation, MyelomonocyticCell Line, TumorReceptors, Cell SurfaceCopper RadioisotopesSquamous Cell Carcinoma of Head and NeckTreatment OutcomeCarcinoma, Squamous CellFemale

Stichwörter der Autor:innen

CD163biomarkerhead and neck squamous cell carcinomapositron emission tomographytumor-associated macrophages

Substanzen

CD163 AntigenAntigens, CDAntigens, Differentiation, MyelomonocyticReceptors, Cell SurfaceCopper Radioisotopes

Autor:innen und Institutionen

  • Mallinckrodt Institute of Radiology, School of Medicine, Washington University, St. Louis, Missouri.
  • Siteman Cancer Center, School of Medicine, Washington University, St. Louis, Missouri.
  • Department of Medicine, University of Missouri, Columbia, Missouri.
  • Department of Medicine, School of Medicine, Washington University, St. Louis, Missouri.
  • Robert Ebert and Greg Stubblefield Head and Neck Tumor Center, Sitman Cancer Center, School of Medicine, Washington University, St. Louis, Missouri.
  • Department of Otolaryngology-Head and Neck Surgery, School of Medicine, Washington University, St. Louis, Missouri.

Zitieren

APA

Heo, G. S., Li, A., Tao, J., Zaretsky, J. M., Sultan, D., Detering, L., Lahad, D., Luehmann, H., Zhang, X., Zhang, X., Gao, X., Venkatesan, R., Belmar, J., Crowder, R., Voller, P., Mallady, A., Nai, Y. H., Gropler, R., Laforest, R., …, & Liu, Y. (2026). PET Imaging of Tumor-Associated Macrophage Dynamics and Response to Clinical Treatment for Potential Translation. Journal of Nuclear Medicine, 67(11), 1771-1776. https://doi.org/10.2967/jnumed.126.272473

Vancouver

Heo GS, Li A, Tao J, Zaretsky JM, Sultan D, Detering L, et al. PET Imaging of Tumor-Associated Macrophage Dynamics and Response to Clinical Treatment for Potential Translation. Journal of Nuclear Medicine. 2026;67(11):1771-1776. doi:10.2967/jnumed.126.272473

BibTeX
@article{Heo2026,
  author = {Heo, Gyu Seong and Li, Alexandria and Tao, Joan and Zaretsky, Jesse Meir and Sultan, Deborah and Detering, Lisa and Lahad, Divangana and Luehmann, Hannah and Zhang, Xiaohui and Zhang, Xiuli and Gao, Xuefeng and Venkatesan, Rajiu and Belmar, Julie and Crowder, Robert and Voller, Peter and Mallady, Akash and Nai, Ying-Hwey and Gropler, Robert and Laforest, Richard and Lin, Chieh-Yu and Li, Shunqiang and Dehdashti, Farrokh and Puram, Sidharth Venkata and Liu, Yongjian},
  title = {PET Imaging of Tumor-Associated Macrophage Dynamics and Response to Clinical Treatment for Potential Translation},
  journal = {Journal of Nuclear Medicine},
  year = {2026},
  volume = {67},
  number = {11},
  pages = {1771--1776},
  doi = {10.2967/jnumed.126.272473}
}
Kostenlos starten →